Viemed Healthcare (VMD) Asset Writedowns and Impairment (2018 - 2023)

Viemed Healthcare's Asset Writedowns and Impairment history runs 6 years deep, the most recent figure standing at -$4.1 million for Q2 2023.

• Quarterly Asset Writedowns and Impairment rose 15.05% year-over-year to -$4.1 million in Q2 2023, while the trailing twelve-month figure through Mar 2023 was -$732000.0 (down 107.08% YoY) and the FY2022 annual result came in at -$1.4 million, down 120.57% from the prior year.
• Asset Writedowns and Impairment was -$4.1 million for Q2 2023 at Viemed Healthcare, down from $4.1 million in the prior quarter.
• Across five years, Asset Writedowns and Impairment topped out at $9.1 million in Q4 2020 and bottomed at -$6.9 million in Q4 2019.
• A 5-year average of $972866.7 and a median of $1.7 million in 2019 frame the typical range for Asset Writedowns and Impairment.
• Peak annual rise in Asset Writedowns and Impairment reached 86225.0% in 2022, while the deepest fall reached 121675.0% in 2022.
• Viemed Healthcare's Asset Writedowns and Impairment stood at -$6.9 million in 2019, then jumped by 231.41% to $9.1 million in 2020, then sank by 81.95% to $1.6 million in 2021, then slumped by 395.62% to -$4.9 million in 2022, then increased by 15.05% to -$4.1 million in 2023.
• Business Quant data shows VMD's Asset Writedowns and Impairment at -$4.1 million in Q2 2023, $4.1 million in Q1 2023, and -$4.9 million in Q2 2022.